Oral Intake of Lactobacillus helveticus NS8 Alleviates Ovalbumin-Induced Atopic Dermatitis in SKH-1 Hairless Mice

Indian Journal of Microbiology
Jingjing RongLi Wang

Abstract

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease and is driven by strong type 2 immune responses. Lactobacillus helveticus NS8 (NS8), a probiotic strain isolated from Mongolian koumiss, has anti-inflammatory activities. Here, we evaluated the therapeutic potential of NS8 on AD-like skin lesions by using SKH-1 hairless mice that underwent three cycles of epicutaneous sensitization (EC) with ovalbumin (OVA). NS8 (5 × 108 CFU/day) was orally administered to mice from 2 weeks before the first sensitization until the end of the study. NS8 attenuated the symptoms and pathological changes in the skin of AD mice. For example, NS8 reduced epidermal and dermal thickening and significantly restrained the infiltration of mast cells, eosinophils, and CD4+ T cells into the dermis. By analysing the Th1/Th2 cytokines produced in skin lesions, we found that NS8 significantly suppressed the expression of IL-4, IL-5, and IL-13 (P < 0.05), while it had no discernible effect on the expression of IFN-γ. Systemically, NS-8 reduced the total IgE and OVA-specific IgE levels in serum (P < 0.05). Our study demonstrates that oral administration of L. helveticus NS8 effectively alleviates AD severity in mice by suppressing the Th...Continue Reading

References

Aug 2, 2003·International Immunopharmacology·Yoshifumi TaniguchiMasashi Kurimoto
Sep 5, 2014·Microbial Cell Factories·Marijke E Segers, Sarah Lebeer
Jan 3, 2015·Current Topics in Microbiology and Immunology·Jin-Shu HeMaria A Curotto de Lafaille
May 1, 2015·Annals of Nutrition & Metabolism·Sophie Nutten
May 6, 2015·The Journal of Allergy and Clinical Immunology·Tali CzarnowickiEmma Guttman-Yassky
May 6, 2016·Frontiers in Microbiology·Irfan A RatherYong-Ha Park
Jul 16, 2016·Expert Review of Clinical Immunology·Robert Kantor, Jonathan I Silverberg
Dec 10, 2016·The Journal of Allergy and Clinical Immunology·Ekaterina AvershinaKnut Rudi
Jan 11, 2017·Critical Reviews in Food Science and Nutrition·Ruby YadavPratyoosh Shukla
Apr 10, 2017·The Journal of Allergy and Clinical Immunology·Patrick M BrunnerDonald Y M Leung
Apr 20, 2017·Frontiers in Microbiology·Dinesh K DahiyaPratyoosh Shukla
Jul 20, 2017·Clinical, Cosmetic and Investigational Dermatology·Sandrine Blanchet-RéthoréPhilippe Andres
Sep 20, 2017·Nature Immunology·Bart N Lambrecht, Hamida Hammad
Nov 13, 2017·Current Opinion in Immunology·Milena Sokolowska, Cezmi A Akdis

❮ Previous
Next ❯

Citations

Jun 1, 2021·Microbiome·Manon BoxbergerBernard La Scola

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
ELISA

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

© 2022 Meta ULC. All rights reserved